Yidu tech ai kong friday 531m

Yidu tech ai kong friday 531m Stock Price Rises 53%

The Yidu tech ai kong friday 531m stock price is surging after a 53% rise since its IPO in May. It is forecasting 43% revenue growth over the next four years. However, the looming global recession could slow the momentum. In addition, the company is facing the threat of stricter Covid control measures in case of pandemics.

Also Read: crypto rich deluxe trading cards


The Yidu tech ai kong friday 531m IPO raises HK$4.1 billion ($531 million). The deal was co-sponsored by Goldman Sachs Group Inc. and China International Capital Corp. and included seven cornerstone investors, including Tencent. Tencent and the other cornerstone investors invested a total of $210 million in the IPO.

The company is a leader in China’s growing smart healthcare market. According to its latest quarterly financials, Yidu ranked first in healthcare intelligence for regulators and medical institutions, as well as in the total market. In the first quarter of 2019, Yidu has already processed 2.6 billion healthcare records for over 600 million patients, and it has analyzed over 1,000 diseases.

Growth outlook

The slowdown in China’s economy has impacted many companies, including Yidu Tech Inc., which is listed on the HKEx. The company did not comment on the reason for the slowdown, but many other Chinese companies have reported similar slowdowns in the second half of the year. In addition to declining revenue, these companies are also facing strict Covid control measures, which force them to suspend operations in certain areas. Despite the slowdown, Yidu’s biggest revenue contributor, its health management platform, grew by 10.7% in revenue last year.

Yidu tech ai kong friday 531m is part of a new breed of big data medical companies that are aiming to improve the efficiency of the healthcare system in China. The country’s population is growing older, and the government is trying to ensure that everyone has access to high-quality healthcare. As a result, many pharmaceutical and medical enterprises are now seeking to make use of big data technology to help them make more accurate decisions about patients. This is a burgeoning industry in China, and Frost & Sullivan estimates that it will grow to be worth over 1.1 trillion yuan by 2030.

The company continues to invest in developing its big data systems. In its latest fiscal year, the company increased R&D spending by 66.2%, outpacing revenue growth and accounting for 29.8% of total revenue. Yidu’s crown jewel, YiduCore, has already processed more than 600 million patient healthcare records. This database covers over 800 hospitals and more than 1,000 diseases. This means that the company has an impressive database of health records that can help doctors make better decisions, which can improve patient care.

Investments in core big data systems

Yidu tech ai kong friday 531m is making a big bet on core big data systems in order to keep its growth going. The company has increased the number of shares allocated to individual investors by about five million, bringing its total shares issued to 78.2 million. The company has also attracted a number of cornerstone investors, including Tencent and China International Capital Corp., which will invest a combined $210 million in the company. The company will also benefit from its strong business model and its commitment to data privacy.

Yidu Tech’s core business is providing service solutions to the healthcare industry, government health management, and medical research. Its services help the industry cut costs and increase efficiency. It also aims to make precision healthcare available to everyone.

The company is also focused on reducing the cost of new drug development by leveraging its healthcare AI platform. It has successfully helped an alliance partner optimize the R&D design of a new drug to treat a rare disease. As a result, the Phase II clinical trial was shortened by 20 months. Its AI technology has also helped a leading MNC client to accelerate a Phase III cardiovascular trial. In this trial, the company was able to double the recruitment efficiency and reduce the screening failure rate by 60%.

Yidu Tech has a focus on expanding healthcare coverage and accessibility in China. It has developed an AI-driven solution for diabetes that enables disease management on a regional level. This helps reduce the incidence of chronic diseases in less developed areas. The company has already tested its algorithms in 18 cities in China, which are based on comprehensive disease insights.


Investors in Yidu Tech Ai Kong’s stock have the opportunity to reap the benefits of its continued focus on building a diverse, inclusive, and equitable work environment. More than half of the company’s workforce is made up of women, and the Board of Directors is made up of equal numbers of male and female members. In addition, the CEO and CFO are both women, and the company has launched the “Dandelion Project,” which seeks to spread the company’s naturalness culture.

Yidu tech ai kong friday 531m offers healthcare AI solutions that facilitate regional population health management and prevent the onset of infectious diseases. These solutions have the potential to reduce mortality in less-developed regions of China. The company’s models, which were developed using extensive disease insights and AI technology, have been validated in eighteen cities, and they are capable of dealing with the full range of 40 infectious diseases defined by the Chinese CDC.

Yidu has invested heavily in privacy and data security. As a result, the company is one of only three healthcare technology companies in China to receive CAICT certification for its secure multi-party computing and federated learning capabilities. Furthermore, Yidu has an impressive portfolio of patents, with over 1,000 granted and registered patents.

Yidu Tech is a rising star in the China’s big data medical industry, which aims to boost efficiency across the healthcare system in the country. As the country’s population ages, it is important to provide quality, affordable healthcare to all citizens. Because of this, medical enterprises are increasingly seeking out big data services to help improve their processes and improve patient care. While the medical intelligence industry in China is still in its infancy, it has tremendous potential for growth. Analysts estimate that the industry will be worth more than 1.1 trillion yuan by 2030.

Stock price

Yidu tech ai kong friday 531m stock price is part of the new generation of big data medical companies in China, which focuses on increasing healthcare efficiency and quality. As China’s population grows older, the need for better healthcare is increasing. As a result, pharmaceutical and medical enterprises are turning to big data analytics to enhance patient care. This industry is relatively new in China, but according to Frost & Sullivan, it will be worth 1.1 trillion yuan by 2030.

The stock price of Yidu Tech AI Hong Friday 531m is up nearly 53% from its May IPO, and the company has forecasts of revenue growth of 43% over the next four years. However, the looming global recession could dampen the stock’s momentum. In addition, the company faces the threat of tighter regulations on the use of Covid in the event of more pandemic flare-ups.

In addition to large institutional investors, retail investors were also interested in Yidu Tech’s IPO. Demand for Yidu’s shares exceeded the supply by nearly one-third. It was the third-highest retail subscription rate in the past 12 months. It also showed that Hong Kong’s IPO market has a growing appetite among retail buyers. As a result, health care and technology IPOs have become hot commodities. If you want to get latest information just follow us https://cryptohike.in/

Relevant Post:










Please enter your comment!
Please enter your name here